---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-060706"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T02:41:33.628175+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences raises ~$6.3M to boost equity above Nasdaq $2.5M minimum

## Summary
- Raised $3.64M (593K shares) via ATM June 3-6, and $2.64M (1.05M shares) in direct offering June 9.
- Proceeds brought stockholders' equity from $1.2M to above the $2.5M Nasdaq minimum.
- Despite cure, delisting risk remains; Nasdaq hearing requested to stay suspension.
- Company previously disclosed non-compliance with Nasdaq Listing Rule 5550(b)(1) on May 28, 2025.

## SEC filing metadata
- accession: 0001104659-25-060706
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925060706/0001104659-25-060706-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925060706/tm2518350d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-060706
- JSON: https://secwatch.observer/filing/0001104659-25-060706.json
- Plain text: https://secwatch.observer/filing/0001104659-25-060706.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.